RONALD E. BLAYLOCK - 25 Apr 2024 Form 4 Insider Report for PFIZER INC (PFE)

Role
Director
Signature
Susan E. Grant, by power of atty., for Ronald E. Blaylock
Issuer symbol
PFE
Transactions as of
25 Apr 2024
Transactions value $
$205,000
Form type
4
Filing time
26 Apr 2024, 13:21:04 UTC
Previous filing
05 Jul 2023
Next filing
12 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Phantom Stock Units Award $205,000 +8,116 +16% $25.26 58,627 25 Apr 2024 Common Stock 8,115 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each unit represents one phantom share of common stock.
F2 Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.
F3 These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.